SeaStar Medical receives Nasdaq MVLS deficiency notice; regains bid price compliance

SeaStar Medical Holding Corp

On June 24, 2024, SeaStar received Nasdaq deficiency letter for MVLS below $35M minimum for 35 consecutive days.
Compliance period ends Dec 23, 2024; no imminent delisting.
On June 27, 2024, Nasdaq confirmed bid price compliance regained after 1-for-25 reverse stock split on June 7.
Company evaluating options to address MVLS deficiency, including possible extension or appeal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.